Posted by admin on May 20th, 2022
Retractable Technologies (NYSE:RVP – Get Rating) is one of 213 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its rivals? We will compare Retractable Technologies to related companies based on the strength of its institutional ownership, profitability, earnings, risk, analyst recommendations, valuation and dividends.
Retractable Technologies has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Comparatively, Retractable Technologies’ rivals have a beta of 1.13, meaning that their average share price is 13% more volatile than the S&P 500.
This table compares Retractable Technologies and its rivals’ net margins, return on equity and return on assets.
This table compares Retractable Technologies and its rivals top-line revenue, earnings per share (EPS) and valuation.
Retractable Technologies’ rivals have higher revenue and earnings than Retractable Technologies. Retractable Technologies is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
This is a breakdown of current recommendations for Retractable Technologies and its rivals, as reported by MarketBeat.
As a group, “Surgical & medical instruments” companies have a potential upside of 60.20%. Given Retractable Technologies’ rivals higher probable upside, analysts plainly believe Retractable Technologies has less favorable growth aspects than its rivals.
23.7% of Retractable Technologies shares are owned by institutional investors. Comparatively, 50.7% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 49.5% of Retractable Technologies shares are owned by company insiders. Comparatively, 14.3% of shares of all “Surgical & medical instruments” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Retractable Technologies beats its rivals on 6 of the 10 factors compared.
About Retractable Technologies (Get Rating)
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
$0.45 EPS Expected for Centennial Resource Development, Inc. (NASDAQ:CDEV) This Quarter
Credit Suisse Group Begins Coverage on Diversey (NASDAQ:DSEY)